UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

Filed by the Registrant  ☒                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

 Preliminary Proxy Statement
 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 Definitive Proxy Statement
 Definitive Additional Materials
 Soliciting Material under Rule 14a-12
AMERINST INSURANCE GROUP, LTD.
(Name of registrant as specified in its charter)
        
(Name of person(s) filing proxy statement, if other than the registrant)
Payment of Filing Fee (Check the appropriate box):
 No fee required.
 Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 (1) 

Title of each class of securities to which transaction applies:

 

 

  

 

 (2) 

Aggregate number of securities to which transaction applies:

 

 

  

 

 (3) 

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

  

 

 (4) 

Proposed maximum aggregate value of transaction:

 

 

  

 

 (5) Total fee paid:
      
  

 

 Fee paid previously with preliminary materials.
 Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 (1) 

Amount Previously Paid:

 

 

  

 

 (2) 

Form, Schedule or Registration Statement No.:

 

 

  

 

 (3) 

Filing Party:

 

 

  

 

 (4) 

Date Filed:

 

 

  

 

 

 

 


AmerInst Insurance Group, Ltd.

c/o Citadel Management Bermuda Limited

Continental Building, 25 Church Street Continental Building

P.O. Box HM 1601

Hamilton, HM GX, Bermuda

 

 

NOTICE OF ANNUAL GENERAL MEETING

June 6, 20193, 2020

 

 

Notice is hereby given that the Annual General Meeting of AmerInst Insurance Group, Ltd. will be held at The Westin Grand Cayman Seven Mile Beach Resort & Spa, Seven Mile Beach, Grand Cayman, Cayman Islands,the office of Citadel Management Bermuda Limited located at the Continental Building, 25 Church Street, Hamilton, HM 12, Bermuda, on Thursday,Wednesday, June 6, 2019,3, 2020, at 10:00 a.m., local time (the “Annual General Meeting”), for the following purposes:

 

1.

To consider and act upon the nomination of each of Stuart H. Grayston, Jerome A. Harris,Irvin F. Diamond, Jeffry I. Gillman, and David N. ThompsonR. Klunk for election as a director with a three-year term;

 

2.

To consider and approve a nonbinding advisory proposal on executive compensation;

3.

To consider and approve a nonbinding advisory vote on the frequency of the advisory vote on executive compensation;

4.

To ratify the appointment of Deloitte Ltd. as our independent auditor for fiscal year 2019;2020; and

 

5.3.

To transact such other business as may properly come before the Annual General Meeting or any adjournment thereof.

You can vote at the Annual General Meeting in person or by proxy if you were a shareholder of record on April 15, 2019.13, 2020. Copies of our proxy statement, a proxy card, and our annual report accompany this notice. It is important that your shares are represented at the Annual General Meeting whether or not you plan to attend.To ensure that you will be represented, we ask that you complete, sign, date and return the enclosed proxy card as soon as possible.We request all shareholders, whether or not they expect to attend the Annual General Meeting in person, to vote their shares. The proxy is revocable at any time prior to its use.

We are actively monitoring the public health and travel safety concerns relating toCOVID-19 pandemic and the advisories or mandates that federal, state, and local governments, and related agencies, may issue. We intend to hold the Annual General Meeting in person. However, in the event it is not possible or advisable to do so as currently planned, we may decide to hold the Annual General Meeting at a different date, time, location or solely by means of remote communication (i.e., a virtual-only or “hybrid” meeting). We will announce this decision via a press release and posting details on our website. If you are planning to attend our Annual General Meeting, please check our website the week of the meeting.

We appreciate your cooperation.

 

By order of the Board of Directors
LOGO
Irvin F. Diamond
Chairman of the Board
April 26, 201927, 2020

 

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF

PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING

TO BE HELD ON JUNE 6, 2019.3, 2020

The Proxy Statement and our 20182019 Annual Report onForm10-K are

available athttp://www.amerinst.bm/investorinfo.html


AMERINST INSURANCE GROUP, LTD.

 

 

PROXY STATEMENT

ANNUAL GENERAL MEETING

JUNE 6, 20193, 2020

 

 

GENERAL INFORMATION

We have sent you this proxy statement because our Board of Directors (the “Board”) is soliciting your proxy to vote your shares of AmerInst Insurance Group, Ltd. at our upcoming Annual General Meeting for 2019,2020, and at any postponement or adjournment thereof. The Annual General Meeting is to be held at 10:00 a.m., local time, on June 6, 2019,3, 2020, at The Westin Grand Cayman Seven Mile Beach Resort & Spa, Seven Mile Beach, Grand Cayman, Cayman Islands.the office of Citadel Management Bermuda Limited located at the Continental Building, 25 Church Street, Hamilton, HM 12, Bermuda.

If your proxy card is properly executed and returned in a timely manner, it will be voted at the Annual General Meeting according to the directions you provide. If you submit a signed proxy card without indicating your vote, the person voting the proxy will vote your shares according to the Board’s recommendations. Your shares will also be voted on any other matters presented for a vote in accordance with the judgment of the persons acting under the proxies. You can revoke your proxy at any time before your shares are voted by delivering a written revocation notice or duly executed form of proxy bearing a later date, prior to the Annual General Meeting, to AmerInst Insurance Group, Ltd., c/o Citadel Management Bermuda Limited, Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda, attention: Corporate Secretary, or by voting in person at the Annual General Meeting.

Our principal executive offices are located at Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda (telephone (441)295-6015). This Proxy Statement is dated April 26, 2019,27, 2020, and we expect to mail proxy materials to you beginning on or about that date. In this Proxy Statement, the words “Company,” “we,” “our,” “ours,” and “us” refer to AmerInst Insurance Group, Ltd. and its subsidiaries. References to “AMIG” refer to our predecessor entity, AmerInst Insurance Group, Inc., a Delaware corporation.

SHARES OUTSTANDING AND VOTING RIGHTS

Only shareholders of record at the close of business on April 15, 2019,13, 2020, are entitled to vote at the Annual General Meeting. The only issued and outstanding voting stock is our common stock, $1.00 par value per share (“Common Stock”), of which 995,253 shares were outstanding on the record date. Each share of Common Stock is entitled to one vote. To hold the Annual General Meeting, we need at least two persons present in person at the Annual General Meeting and representing in person or by proxy at leastone-third of the total issued and outstanding shares of Common Stock.

In order to assure the presence of a quorum, we urge you to promptly complete, sign, date and return the enclosed proxy card, whether or not you plan to attend the Annual General Meeting in person.

Each of the matters intended to be presented at the Annual General Meeting and described in this proxy statement requires the affirmative vote of the majority of votes cast thereon. If you are otherwise entitled to vote, your vote may be cast in person or by proxy. On the proposal to ratify the appointment of Deloitte Ltd., you can vote to “abstain.” If you vote to “abstain,” your shares will not be counted in the determination of the shares of Common Stock voting on such matter, but are counted for quorum purposes. Brokernon-votes are also not counted in the vote but are counted for quorum purposes. If you own shares held of record by another person and want to vote in person, you must obtain a legal proxy from the record holder and bring it to the Annual General Meeting.


Security Ownership of Certain Beneficial Owners and Management

The following table sets forth information as of April 1, 2019,2020, with respect to beneficial ownership of our Common Stock by each person who, to our knowledge, is a holder of more than 5%1% of our Common Stock and each of our directors, director nominees and officers and all directors and officers as a group.

Unless otherwise indicated, the persons named in the table have sole voting and investment power with respect to all shares shown as beneficially owned by them. Except as otherwise noted, all information in the table and the accompanying footnotes is given as of April 1, 2019,2020, and has been supplied by each of the persons included in the table.

 

Name of Beneficial Owner(1)

  Number of Shares
Beneficially Owned
  Percent of
Shares
Beneficially
Owned
  Number of Shares
Beneficially Owned
   Percent of
Shares
Beneficially
Owned
 

5% or Greater Shareholders

          

AmerInst Investment Company, Ltd.(2)

    348,606    35.0%   369,576    37.1

Named Executive Officers and Directors

          

Jerome A. Harris, CPA(3)

    10,822    1.1%   12,179    1.2

Irvin F. Diamond, CPA(4)

    17,322    1.7%   18,679    1.9

David R. Klunk, CPA(5)

    13,622    1.4%   14,979    1.5

David N. Thompson(6)

    9,122    *   10,479    1.1

Jeffry I. Gillman, CPA(7)

    10,322    1.0%   11,679    1.2

Stuart H. Grayston(8)

    5,374    *   6,731    * 

Thomas B. Lillie, CPA(9)

    9,121    *   10,478    1.1

F. Kyle Nieman III(10)

    1,000    *   2,000    * 
   

 

    

 

   

 

   

 

 

All Directors and Officers as a Group (9 Persons)

    76,705    7.7%

All Directors and Officers as a Group (8 Persons)

   87,204    8.8

 

 *

Represents less than 1% of our outstanding Common Stock.

(1)

The address of each such personbeneficial owner is c/o Citadel Management Bermuda Limited, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda.

(2)

AmerInst Investment Company, Ltd. is a wholly owned indirect subsidiary of the Company. Under Bermuda law, AmerInst Investment Company, Ltd. is entitled to vote the Common Stock held by it at the Annual General Meeting. AmerInst Investment Company, Ltd. has indicated that it intends to vote the Common Stock it holds in accordance with the Board’s recommendations for each of the proposals.

(3)

A director. Includes 8,8229,179 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(4)

A director. Includes 15,32215,679 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(5)

A director. Includes 11,62211,979 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(6)

A director. Includes 7,1227,479 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(7)

A director. Includes 8,3228,679 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(8)

A named executive officer and director. Includes 3,3743,731 shares of Common Stock and 2,0003,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

(9)

A director. Includes 7,1217,478 shares that are held by the Thomas B. Lillie Trust U/A/D 6/7/90, of which Mr. Lillie is the sole trustee, and has sole voting and investment power with respect to those shares. Mr. Lillie’s beneficial ownership also includes 3,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2020.

(10)

A named executive officer. Includes 2,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.

(10)

A named executive officer. Includes 1,000 vested options to acquire Common Stock that are exercisable within 60 days of April 1, 2019.2020.

 

2


Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the U.S. Securities Exchange Act of 1934 requires our officers and directors, and persons who own more than 10% of our Common Stock, to file reports of ownership with the SEC. These persons are also required to furnish us with copies of all Section 16(a) forms they file.

Aside from the one instance discussed in the paragraph below and basedBased solely upon a review of these reports received by us during 20182019 and any written representations from reporting persons, we believe that during 20182019 each required Section 16(a) report was filed on time.

As of January 1, 2011, Thomas B. Lillie was no longer a shareholder or a board member of Lewis & Knopf, P.C., and thus, was no longer the beneficial owner of 1,899 shares of the Company’s Common Stock owned by Lewis & Knopf, P.C. This change in beneficial ownership was not filed on Form 4, but on February 6, 2019, a Form 5 was filed to reflect this change.

Certain Relationships and Related Persons Transactions

We recognize that transactions between us and any of our directors or executive officers can present potential or actual conflicts of interest and create the appearance that our decisions are based on considerations other than our and our shareholders’ best interests. Therefore, as a general matter, it is our preference to avoid these types of transactions. Nevertheless, we recognize that there are situations where these types of transactions may be in, or may not be inconsistent with, our best interests. Therefore, our ethics policy prohibits us from entering into these types of transactions, except those approved or ratified by the Board of Directors. The Board of Directors has adopted a Code of Ethics applicable to our President and our financial and accounting officers, which may be viewed at our website,http://www.amerinst.bm/investor-information/. Our Code of Ethics is designed to comply with Securities and Exchange Commission requirements. We will disclose any amendments to, or waivers from, the Code of Ethics on our website within four business days of such determination. We do not have any formal written policy separately addressing transactions reported under Item 404(a) of the SEC’s RegulationS-K. The only transaction during 20182019 reportable under Item 404(a) was the payment for management services to Citadel Management Bermuda Limited (“Citadel Management”). This payment was made pursuant to our management agreement with Citadel Management, which was approved at the time it was originally entered into and at the time of each subsequent amendment by all of our directors not affiliated with Citadel Management. Any amendments, new management agreements or other payments to Citadel Management will be subject to the same approval process.

Citadel Management provides management services to us pursuant to a management agreement. We paid Citadel Management $327,500$353,000 pursuant to this agreement during 2018.2019. Mr. McMahon, who serves as our Treasurer and Chief Financial Officer, is the President and a shareholder of Citadel Management. The approximate dollar value of Mr. McMahon’s interest in the foregoing transaction, without regard to profits or losses, was $53,492.$57,657.

 

3


ITEM  1—ELECTION OF DIRECTORS

Our Board currently has seven members. Ourbye-laws provide that the Board shall have no fewer than five and no more than nine directors. Ourbye-laws divide the directors into three classes. The directors in a given class are elected for three-year terms, and the term of each class expires in successive years. Our Board, upon the recommendation of our Governance and Nominating Committee, has nominated Stuart H. Grayston, Jerome A. Harris,Irvin F. Diamond, Jeffry I. Gillman, and David N. Thompson,R. Klunk, whose terms expire this year, to stand again for election to the Board. If elected, Messrs. Grayston, Harris,Diamond, Gillman, and ThompsonKlunk would each serve a three-year term expiring at the 20222023 Annual General Meeting, or until his successor is duly elected and qualified. Unless you otherwise instruct us, your properly executed proxy will be voted for the election of Messrs. Grayston, Harris,Diamond, Gillman, and Thompson.Klunk. If any of the nominees are unable to serve, the enclosed proxy confers authority upon the designated proxies to vote in favor of such other person to serve in place of such nominee as the Board recommends.

Qualifications of Directors

The following paragraphs provide information (i.e.(i.e., age, all positions held, principal occupation and business experience for the past five years, and names of other publicly held companies for which he serves as a director or has served as a director during the past five years), as of the date of this Proxy Statement, about each nominee and incumbent director. While the following paragraphs note certain individual qualifications and skills of our nominees and incumbent directors that contribute to the Board’s effectiveness as a whole, we also believe that each nominee and incumbent director has a reputation for integrity, honesty, and adherence to high ethical standards. The Board believes that each has demonstrated strong leadership skills, business acumen and an ability to exercise sound judgment, as well as a commitment of service to our shareholders. Additionally, there are no family relationships between any of our directors, executive officers, or any person nominated or chosen to become a director or executive officer.

Nominees for Election as Director for a three-year term expiring in 2023

Irvin F. Diamond,CPA, age 78, has been a director since 1999 and our Chairman since 2007. He is currently an employee of REDW, LLC, a certified public accounting firm, and previously served as a principal of REDW, LLC from 1976 until 2017. He is a former member and Vice President of the AICPA Board of Directors and a former President of the New Mexico Society of Certified Public Accountants. Until November 30, 2017, he was a Certified Public Accountant, a Certified Financial Planner, an AICPA Personal Financial Specialist and a Registered Investment Advisor. We believe Mr. Diamond’s qualifications to sit on our Board include his over 55 years of public accounting experience as well as his other board experiences and his long history with us.

Jeffry I. Gillman, CPA, age 78, has been a director since 1999. Mr. Gillman has been actively engaged in public accounting since 1964 and the President of Gillman, Shapiro & Dillemuth, P.A., his certified public accounting practice in Stuart, Florida since 1977. He was a former member of the AICPA Professional Liability Insurance Plan Committee, a founding Trustee of the Florida Institute of Certified Public Accountants Health Benefit Trust and Vice President of the Florida Institute of Certified Public Accountants. We believe Mr. Gillman’s qualifications to sit on our Board include his 55 years of public accounting experience as well as his 22 years of professional liability insurance experience.

David R. Klunk, CPA, age 68, has been a director since 2008. Mr. Klunk was employed with Philip R. Friedman and Associates LLP, a certified public accounting firm in York, Pennsylvania from 1974 until 2010, at which time he served as Managing Partner. In 2010, the firm merged with Reinsel Kuntz Lesher LLP (now RKL LLP), a regional certified public accounting firm in Pennsylvania. Mr. Klunk continued as a partner with that firm until 2014. Mr. Klunk continues to serve as a consultant and director for the firm. He is also a member of the AICPA as well as the Pennsylvania Institute of Certified Public Accountants. Mr. Klunk is a director and board consultant of severalnon-public companies, in addition to holding offices and chairing committees of local civic, charitable and religious organizations. We believe Mr. Klunk’s qualifications to sit on our Board include his over 46 years of public accounting experience as well as his experience on other boards.

4


The board recommends that you vote “FOR” the election of the director nominees above.

Director Continuing in Office—term expiring in 2021

Thomas B. Lillie,CPA, CFP, PFS, age 67, has been a director since 2007. He is a former Principal and current employee of Lewis & Knopf, P.C., a certified public accounting firm in Flint, Michigan, where he has been employed since 1974. His experience includes: audits ofnon-public companies including a dental insurance company; preparation of audited, reviewed and compiled financial statements; preparation of corporate, partnership, estate, trust and personal income tax returns; accounting for small- tomedium-sized businesses; assisting business startups; and consulting with businesses to help them increase their net income and future value, and develop business succession plans. He is a member of the firm’s estate, trust, and personal financial planning practice. He is a member of the American Institute of Certified Public Accountants and the Michigan Association of Certified Public Accountants. In addition to being a certified public accountant, he is a Certified Financial Planner and an AICPA Personal Financial Specialist. He presents on various business and tax topics to local business organizations. We believe Mr. Lillie’s qualifications to sit on our Board include his over 46 years of public accounting experience as well as his previous experience managing a seven-partner accounting firm.

Directors Continuing in Office—terms expiring in 2022

Stuart H. Grayston, age 78,79, has been a director and our President since 2002. He was President, Offshore Operations of USA Risk Group from 2001 until 2010, and Vice-President and Director of Cedar Management Limited (f/k/a CNA Risk Services Ltd. and successor to USA Risk Group (Bermuda) Ltd.) from 2008 until 2010. He was the founder of Grayston Consulting Services and has been its President since 1993. Mr. Grayston was with Frank B. Hall & Company, Inc. from 1988 to 1992 as President and CEO of their worldwide Alternative Market Division, which included captive management operations in Bermuda, Vermont, and Colorado. Prior to 1988, Mr. Grayston was President of Skandia Insurance Management and Hanna Insurance Management in Bermuda, which merged with a captive insurance management firm in Bermuda that Mr. Grayston established in 1977. We believe Mr. Grayston’s qualifications to sit on our Board include his over 5152 years of insurance, reinsurance, and captive management experience as well as his experience on numerous boards and chairing industry associations.

Jerome A. Harris, CPA, age 76,77, has been a director since 1998 and our Vice Chairman since 2003. He was a director of AMIG from 1995 to 1999, its Secretary and Assistant Treasurer from 1998 to 1999 and its Assistant Secretary and Assistant Treasurer from 1995 through 1998. Mr. Harris also served as a director of Sun Holdings LLC, until 2017, which is a holding company for a proprietary trading company and its subsidiaries and affiliates. He has been the Managing Partner of the Harris Consulting Group, LLC, and a Partner in the consulting firm, The Pivotal Factor, LLC, since 2003.from 2003 to 2010. He was the Managing Partner of Checkers, Simon & Rosner, LLP, a certified public accounting firm in Chicago, Illinois, from 1978 to 2003. He was Senior Managing Director of American Express Tax and Business Services from 1997 to 2003 and a Partner of Altschuler, Melvoin and Glasser, LLP, a certified public accounting firm, from 1999 to 2003. Mr. Harris was a founding and past board member and past member of the Executive Committee of the Accountants Liability Assurance Company, Ltd.; former Chairman of the Illinois CPA Society Insurance Liability Task Force; a former member of the governing council of the AICPA; and former Vice Chairman, Secretary and Director of the Illinois CPA Society. We believe Mr. Harris’s qualifications to sit on our Board include his over 4748 years of public accounting experience as well as his service on numerous advisory boards and his experience as a business owner.

4


David N. Thompson, age 68,69, has been a director since 1998 and our Assistant Secretary since 1999. From 1998 to 1999, he was a director of AMIG. He is an Internet entrepreneur; in addition, he has been Chairman and Chief Executive Officer ofE-Insure Services, Inc., an Internet insurance marketplace, which operates EINSURANCE.com, since 1996, and President of Insure Specialists Services, Inc., an insurance consulting firm,

5


since 2004. He also held positions as President and CEO of Millers American Group in 1998 and 1999 and as Senior Vice President—Mergers and Acquisitions at Meadowbrook Insurance Group, Inc., in 1998. Prior to 1998, Mr. Thompson was the Practice Leader of the Alexander and Alexander Affinity Group, and Chairman, President and Chief Executive Officer of Crum & Forster Managers Group, an underwriter of property and casualty insurance and the predecessor to Coregis Insurance Company. He is also an inactive certified public accountant. We believe Mr. Thompson’s qualifications to sit on our Board include his significant insurance experience as well as his experience as a business owner.

The board recommends that you vote “FOR” the election of the director nominees above.

Directors Continuing in Office—terms expiring in 2020

Irvin F. Diamond,CPA, age 77, has been a director since 1999 and our Chairman since 2007. He is currently an employee of REDW LLC, a certified public accounting firm, and previously served as a principal of REDW, LLC from 1976 until 2017. He is a former member and Vice President of the AICPA Board of Directors and a former President of the New Mexico Society of Certified Public Accountants. Until November 30, 2017, he was a Certified Public Accountant, a Certified Financial Planner™, an AICPA Personal Financial Specialist and a Registered Investment Advisor. We believe Mr. Diamond’s qualifications to sit on our Board include his over 54 years of public accounting experience as well as his other board experiences and his long history with us.

Jeffry I. Gillman, CPA, age 77, has been a director since 1999. Mr. Gillman has been actively engaged in public accounting since 1964 and the President of Gillman, Shapiro & Dillemuth, P.A., his certified public accounting practice in Stuart, Florida since 1977. He was a former member of the AICPA Professional Liability Insurance Plan Committee, a founding Trustee of the Florida Institute of Certified Public Accountants Health Benefit Trust and Vice President of the Florida Institute of Certified Public Accountants. We believe Mr. Gillman’s qualifications to sit on our Board include his 54 years of public accounting experience as well as his 21 years of professional liability insurance experience.

David R. Klunk, CPA, age 67, has been a director since 2008. Mr. Klunk was employed with Philip R. Friedman and Associates LLP, a certified public accounting firm in York, Pennsylvania from 1974 until 2010, at which time he served as Managing Partner. In 2010, the firm merged with Reinsel Kuntz Lesher LLP (now RKL LLP), a regional certified public accounting firm in Pennsylvania. Mr. Klunk continued as a partner with that firm until 2014. Mr. Klunk continues to serve as a consultant and director for the firm. He is also a member of the AICPA as well as the Pennsylvania Institute of Certified Public Accountants. Mr. Klunk is a director and board consultant of severalnon-public companies, in addition to holding offices and chairing committees of local civic, charitable and religious organizations. We believe Mr. Klunk’s qualifications to sit on our Board include his over 45 years of public accounting experience as well as his other board experiences.

Director Continuing in Office—term expiring in 2021

Thomas B. Lillie,CPA, CFP™, PFS, age 66, has been a director since 2007. He is a former Principal and current employee of Lewis & Knopf, P.C., a certified public accounting firm in Flint, Michigan, where he has been employed since 1974. His experience includes: audits ofnon-public companies including a dental insurance company, preparation of audit, reviewed and compiled financial statements, preparation of corporate, partnership, estate, trust and personal income tax returns, accounting for small- tomedium-sized businesses, assisting business startups, and consulting with businesses to help them increase their net income, future value and develop business succession plans. He is a member of the firm’s estate, trust, and personal financial planning

5


practice. He is a member of the American Institute of Certified Public Accountants and the Michigan Association of Certified Public Accountants. In addition to being a certified public accountant, he is a Certified Financial Planner™ and an AICPA Personal Financial Specialist. He presents on various business and tax topics to local business organizations. We believe Mr. Lillie’s qualifications to sit on our Board include his over 44 years of public accounting experience as well as his previous experience managing a seven-partner accounting firm.

Non-Director Executive Officers

Thomas R. McMahon,FCA, age 56,57, has been our Treasurer and Chief Financial Officer since 2008. Mr. McMahon has been the President, a director, and a shareholder of Citadel Management Bermuda Limited (formerly Cedar Management Limited), our management company, since 2005, and was the Chief Operating Officer of CNA Risk Services Ltd. from 1994 through 2005. Citadel Management Bermuda Limited offers management services for agencies, associations, and insureds wishing to form and operate a captive insurance company. Since his arrival in Bermuda in 1988, Mr. McMahon has been engaged in various aspects of the captive insurance industry from public auditing with PricewaterhouseCoopers to the establishment and management of captive insurance companies. Mr. McMahon graduated with honors with a Bachelors of Commerce degree from the University College Galway, Ireland and is a Fellow of the Institute of Chartered Accountants in Ireland.

F. Kyle Nieman III, age 59,60, has been the President and Chief Executive Officer since 2009 of Protexure Insurance Agency, Inc. (formerly known as AmerInst Professional Services, Limited) (“Protexure”), a Delaware corporation and wholly owned subsidiary of AmerInst Mezco, Ltd., which is a wholly owned subsidiary of the Company. Mr. Nieman was Vice-President of Underwriting for CNA Financial Corporation from 1994 through 2006, Senior Vice-President of CNA Financial Corporation from 2006 through 2008 and an independent contractor for Protexure during 2009. Mr. Nieman holds a Bachelors of Science degree from Indiana University and a Masters of Business Administration from the Illinois Institute of Technology.

Directors

 

Name

  Age   

Position(s)

Irvin F. Diamond

   7778   Chairman of the Board

Jeffry I. Gillman

   7778   Director

Stuart H. Grayston

   7879   Director and President

Jerome A. Harris

   7677   Vice-Chairman of the Board; Chairman of Protexure

David R. Klunk

   6768   Director

Thomas B. Lillie

   6667   Director

David N. Thompson

   6869   Director and Assistant Secretary

Board Leadership Structure

Our Board is led by our Chairman of the Board. Currently, the positions of President (our principal executive officer) and Chairman are held by different persons. The Board does not have a formal policy as to whether the roles of Chairman and President should be separate. At this time, the Board has determined that separating these roles and having an independent director serve as Chairman of the Board is in our best interests and the best interests of our shareholders. The President supervises and administers all of our general business and affairs and the Chairman sets the agenda for, and presides over, meetings of the Board. The Board believes that this structure helps to separate the role of the Chairman in managing the Board, which serves in an oversight capacity, from the oversight responsibilities of the President with regard to managing ourday-to-day operations by our third-party management company, Citadel Management Bermuda Limited.

 

6


Risk Management

The Board believes that risk management is an important component of our corporate strategy. Although the full Board has responsibility for the general oversight of risks, it primarily conducts its risk oversight function through committees, including the Audit Committee and the Governance and Nominating Committee, as well as other committees. The Board is regularly informed through committee reports about our risks and discusses and reviews with management major policies with respect to risk assessment and risk management. Finally, the Board believes the separate roles of Chairman and President (our principal executive officer) assists us in our ability to implement major policies addressing our risks.

Independent Directors

Our Board has determined that Messrs. Diamond, Gillman, Harris, Klunk, Lillie, and Thompson are independent members of our Board under the Nasdaq Marketplace Rules, which we have selected for purposes of determining the independence of our directors and director nominees. There were no transactions, relationships or arrangements considered by the Board of Directors in determining the independence of the foregoing directors which were not disclosed pursuant to Item 404(a) ofRegulationS-K.

Meetings and Committees of the Board

There were seven standing committees of the Board during 2018,2019, constituted as follows:

 

Committee

  

Members

Audit Committee

  Messrs. Gillman (chair), Lillie and Klunk

Compensation Committee

  Messrs. Diamond (chair), Harris and Klunk

Finance Committee

  Messrs. Klunk (chair), Grayston and Gillman

Investment Committee

  Messrs. Lillie (chair), Thompson and Grayston

Governance and Nominating Committee

  Messrs. Harris (chair), Thompson and Lillie

Strategic Planning Committee

  Messrs. Grayston (chair), Diamond, Harris and     Thompson

Underwriting, Actuarial and Reinsurance Committee

  Messrs. Thompson (chair), Harris and Lillie

The seven standing committees, have and may exercise the full power of the Board on matters within the scope of the respective committee’s functions, including the annual audit of our financial statements; review and approval of our fiscal year budget; our investment activity and consideration of various opportunities and options available to us; consideration of nominees to the Board; coordination of press releases and other communications with the public; ownership, transfer or redemption of our Common Stock; and the review and negotiation of reinsurance contracts.

Because none of our executive officers, other than Mr. Nieman in his capacity as an executive officer of Protexure, now receive, nor have historically received, compensation from us for their position as an officer, we have not historically had a standing compensation committee. However, our Board of Directors formed a Compensation Committee in June 2016 and Messrs. Diamond, Harris and Klunk currently serve as members of our Compensation Committee. The Compensation Committee does not have a written charter, but operates under delegated authority from the full Board for matters within its purview. Our Board has determined that Messrs. Diamond, Harris, and Klunk satisfy the Nasdaq independence standards for directors serving on the Compensation Committee. Our Compensation Committee determines the compensation paid to Mr. Nieman and our other executive officers, which is set by the Compensation Committee based on factors it deems relevant in making such determinations. In 2018, the Compensation Committee engaged Pearl Meyer & Partners, LLC (“Pearl Meyer”), a compensation consulting firm, to assist the committee in: (i) reviewing and analyzing executive compensation packages for the executive officers of Protexure, (ii) conducting an independent review of compensation practices at similarly situated companies in our industry and (iii) making executive compensation recommendations to the Compensation Committee. Pearl Meyer issued a report containing its recommendations regarding executive

7


compensation matters. The Compensation Committee has completed their review of this report and have implemented recommendations to executive compensation, and are currently finishing recommended changes to the phantom stock plan. We are not aware of any work done by Pearl Meyer that could raise a conflict of interest that would be required to be disclosed in the proxy statement under applicable SEC rules.

The Board held a total of threefour meetings during 2018.2019. All of our directors attended at least 75% of all Board meetings and committee meetings on which each director serves. During 2018,2019, the Audit Committee met seven times; the Compensation Committee two times;one time; the Finance Committee met threefive times; the Investment Committee

7


met seven times; the Governance and Nominating Committee met three times; the Strategic Planning Committee met fourthree times; and the Underwriting, Actuarial, and Reinsurance Committee met sixnine times.

The Board has adopted a written charter for the Audit Committee, which is available athttp://www.amerinst.bm/investor-information/. The Audit Committee has the authority to consider the qualifications of our independent auditors and make recommendations to the Board as to their suitability for recommendation to the shareholders for appointment; approve any material,non-audit services to be rendered by such independent auditors; and review and resolve any differences of opinion between such independent auditors and management concerning our financial statements. The Audit Committee’s functions include selecting our independent auditors; reviewing the arrangements for, and scope of, the independent auditors’ examination; meeting with the independent auditors and certain of our officers to review the adequacy and appropriateness of our system of internal controls and reporting, our critical accounting policies, and our public financial disclosures; ensuring compliance with our code of ethics; and performing any other duties or functions deemed appropriate by the Board. Messrs. Gillman, Lillie, and Klunk are currently the members of the Audit Committee. Our Board has determined that all of the members of the Audit Committee satisfy the independence requirements for Audit Committee members under the Nasdaq Marketplace Rules and that each member of the Audit Committee qualifies as an “audit committee financial expert” under the rules and regulations of the SEC.

We do not have a formal policy regarding attendance by members of our Board at our annual general meetings, although we strongly encourage our directors to attend such meetings. All of our directors attended the 20182019 Annual General Meeting in person.

Board Member Nominations

The Governance and Nominating Committee operates under a written charter, which is available athttp://www.amerinst.bm/investor-information/.

The Governance and Nominating Committee reviews and makes recommendations to the full Board regarding the composition and size of the Board so that the Board consists of members with the proper expertise, skills, attributes, and personal and professional backgrounds needed by the Board, consistent with the Nasdaq Marketplace Rules. The Governance and Nominating Committee believes that all directors, including nominees, should possess the highest personal and professional ethics, integrity, and values, and be committed to representing the long-term interests of our shareholders. The Governance and Nominating Committee endeavors to have a Board of which all the members have experience in the accounting profession and a background in the business of professional liability insurance or similar areas. The Governance and Nominating committee will consider, when appropriate, other criteria useful to our current and prospective businesses in the nomination process. The Governance and Nominating Committee does not have a formal policy on diversity.

If you are a shareholder entitled to vote at our Annual General Meetings, you may nominate one or more persons for election as a director at the Annual General Meeting. The Governance and Nominating Committee will consider recommendations for nominees for directorships submitted by shareholders and will apply the same evaluation to such recommendations submitted by a shareholder as recommendations submitted by any other person or entity. Shareholders who wish the Governance and Nominating Committee to consider their recommendations for nominees for director should submit their recommendations in writing to the Governance

8


and Nominating Committee in care of the Corporate Secretary at our principal executive offices, in the manner described in the section below entitled “Director Nominations.” Our Board has determined that all of the members of the Governance and Nominating committee are independent as determined under the Nasdaq Marketplace Rules.

Shareholder Communications with the Board of Directors

Any shareholder or other interested party who has a concern or inquiry may communicate directly with either our independent directors or the full Board. Shareholder Relations will receive all such communications on

8


behalf of thenon-employee directors and the full Board. Communications may be confidential or anonymous, and may be submitted in writing to Shareholder Relations, AmerInst Insurance Group, Ltd., c/o Citadel Management Bermuda Limited, Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda. All written communications will be received and processed by our Corporate Secretary and all substantive communications will be referred to Shareholder Relations. All such communications will be reviewed and, if necessary, investigated or addressed by Shareholder Relations and the status of such communications will be reported to the full Board on a regular basis.

Report of the Audit Committee

TO OUR FELLOW SHAREHOLDERS:

The Audit Committee, which operates under a written charter adopted by the Board, monitors the Company’s financial reporting process on behalf of the Board. This report reviews the actions taken by the Audit Committee with regard to the Company’s financial reporting process during 20182019 and particularly with regard to the Company’s audited financial statements.

The Audit Committee believes that it has taken the actions necessary or appropriate to fulfill its oversight responsibilities under the Audit Committee’s charter. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management the audited financial statements to be included in the Company’s Annual Report on Form10-K for the year ended December 31, 2018,2019, including a discussion of the quality (rather than just the acceptability) of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements.

The Audit Committee also reviewed with Deloitte Ltd. their judgments as to quality (rather than just the acceptability) of the Company’s accounting principles and such other matters as are required to be discussed with the Audit Committee in accordance with the Public Company Accounting Oversight Board standards. In addition, the Audit Committee discussed with Deloitte Ltd., the auditor’s independence from management and the Company, including the written disclosures, letter, and other matters required of Deloitte Ltd. by the Public Company Accounting Oversight Board. Additionally, the Audit Committee discussed with the Company’s independent auditors the overall scope and plan for their audit. The Audit Committee met with the independent auditors, with and without management present, to discuss the results of their examinations, their evaluations of the Company’s internal controls, and the overall quality of the Company’s financial reporting.

Based upon these reviews and discussions, the Audit Committee has recommended to the Board of Directors that our audited financial statements be included in our Annual Report on Form10-K for the year ended December 31, 2018,2019, for filing with the U.S. Securities and Exchange Commission.

By the Audit Committee:

Dated March 22, 201920, 2020

Jeffry I. Gillman, Chairman

Thomas B. Lillie

David R. Klunk

9


This report shall not be deemed to be incorporated by reference by any general statement incorporating by reference the Proxy Statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (collectively, the “Acts”), and shall not otherwise be deemed filed under the Acts.

9


Director Compensation

Our full Board sets the compensation for our directors. The Board generally considers whether any change from the prior year’s compensation is appropriate to account for inflation or other factors the Board may deem appropriate. Currently, the directors are paid an annual retainer of $25,000. Of this amount, $10,000 is paid in Common Stock.

In addition to the annual retainer, the directors are also paid $800 perhalf-day for each Board meeting and $200 per hour for each committee meeting attended during the calendar year. Directors are entitled to receive compensation and reimbursement for expenses incurred in attending board or committee meetings or when otherwise acting on our behalf. The Chairman of the Board, as well as the chairman of the Audit Committee and the chairman of the Governance and Nominating Committee, each receives an additional annual retainer of $10,000. The chairman of each other committee receives an additional annual retainer of $5,000.

The following table discloses the compensation received by each of ournon-executive directors in 2018:2019:

DIRECTOR COMPENSATION

 

Name

 Fees Earned
or Paid in
Cash ($)
 Stock Awards(1)  ($) Option
Awards(1)  ($)
 All Other
Compensation ($)
 Total ($)  Fees Earned
or Paid in
Cash ($)
   Stock Awards ($) All Other
Compensation ($)
 Total ($) 

Jerome A. Harris

 $67,750 $10,000 $—   $10,645(2)  $88,395  $74,651   $10,000(1)   $10,011(2)   $94,662 

Irvin F. Diamond

  57,000  10,000  —    14,695(3)   81,695  $56,500   $10,000(1)   $16,461(3)   $82,961 

David R. Klunk

  56,600  10,000  —    5,645(4)   72,245  $44,000   $10,000(1)   $5,811(4)   $59,811 

David N. Thompson

  61,000  10,000  —    11,395(5)   82,395  $60,900   $10,000(1)   $11,561(5)   $82,461 

Jeffry I. Gillman

  61,000  10,000  —    3,995(4)   74,995  $55,800   $10,000(1)   $4,161(4)   $69,961 

Thomas B. Lillie

  59,600  10,000  —    3,395(6)   72,995  $59,400   $10,000(1)   $4,510(6)   $73,910 

 

(1)

As part of their retainer fee for service on the Board from June 20182019 until the 20192020 Annual General Meeting, the directors were awarded grants of stock with a grant date fair value of $10,000, computed in accordance with FASB ASC Topic 718.

(2)

This amount includes dividends in the amount of $4,245$4,411 and $6,400$5,600 for work performed for Protexure.

(3)

This amount includes dividends in the amount of $7,495$7,661 and $7,200$8,800 for work performed for Protexure.

(4)

This amount includes dividends.

(5)

This amount includes dividends in the amount of $3,395$3,561 and $8,000 for work performed for Protexure.

(6)

This amount includes dividends in the amount of $3,395$950 paid on shares owned or recorded by Lewis & Knopf, P.C. of which Mr. Lillie is an employee, and dividends of $3,560 paid on shares of which the Thomas B. Lillie Trust is the record owner. Mr. Lillie is the sole trustee of the Thomas B. Lillie Trust.

Executive Officers

All of our executive officer positions, except for the (i) President and Chief Executive Officer of Protexure and (ii) our Treasurer and Chief Financial Officer, are filled by our directors without any salary or other compensation for service. We have a management agreement with Citadel Management Bermuda Limited, pursuant to which Citadel Management Bermuda Limited has agreed to provide management services to us. This agreement is described under “Other Matters-Certain Relationships and Related Transactions.” Stuart Grayston, our President, was formerly a director and officer of Citadel Management Bermuda Limited (f/k/a Cedar Management) until 2010, and Thomas R. McMahon, our Treasurer and Chief Financial Officer, is currently an

10


officer, director, and employee of Citadel Management Bermuda Limited. Both Mr. Grayston and Mr. McMahon are residents of Bermuda. Mr. Grayston is not compensated by us for serving as our President and Mr. McMahon is not separately compensated by us for serving as our Treasurer and Chief Financial Officer.

10


The following is a list of our executive officers:

 

Name

  Age   

Position(s)

Stuart H. Grayston

   7879   Director and President

Thomas R. McMahon

   5657   Treasurer and Chief Financial Officer

F. Kyle Nieman III

   
59
60
 
  President and Chief Executive Officer of Protexure

The following summary compensation table shows the compensation paid to or received or deferred by Messrs. Nieman III and Grayston for services in all capacities during 20172018 and 2018.2019. Mr. Nieman is the sole executive officer compensated by us in his capacity as an executive officer of Protexure. Mr. Grayston is also included in the summary compensation table because of his role as our President (Principal Executive Officer). As explained above under the section captioned “Item 1—Election of Directors—Director Compensation,” Mr. Grayston is not compensated as our President, but he does receive compensation from us for service on the Board as one of our directors. Other than Messrs. Grayston and Nieman, we do not have any named executive officers.

SUMMARY COMPENSATION TABLE

 

(a)  (b) (c)  (d) (e) (f) (i) (j)

Name and Principal Position

  Year Salary
($)
 Bonus
($)
  Stock
Awards

($)
 Option
Awards

($)
 All Other
Compensation

($)
 Total
($)

Stuart H. Grayston

President and Director

   

20182019

2017


2018

 

  $

 

—  

—  


  $

 

—  

—  


  $


10,000

10,000


(1)(5) 

(3)(5) 

 $

 

—  

5,176


—  

 

 $

 

51,12151,287

60,93951,121

(2)(5) 

(4)(5) 

 $

 

61,12161,287

76,11561,121


F. Kyle Nieman, III

President and CEO of Protexure

   

20182019

2017


2018

 

$

$

347,500

317,500


$

$

17,000

24,200


  $

 

317,500—  

287,500


$

24,200

53,225


$


—  

(6) 

(6) 

 $

28,745

—  $

(7)  

28,745


(7) 

 $

 

—  

—  


 $

$

370,445364,500

340,725370,445


 

(1)

As part of Mr. Grayston’s retainer fee for service on the Board from June 20182019 until the 20192020 Annual General Meeting, he was awarded grants of stock with a grant date fair value of $10,000 computed in accordance with FASB ASC Topic 718.

(2)

This amount includes Director Fees earned or paid in cash in the amount of $49,600 and dividends in the amount of $1,521.$1,687.

(3)

As part of Mr. Grayston’s retainer fee for service on the Board from June 20172018 until the 20182019 Annual General Meeting, he was awarded grants of stock with a grant date fair value of $10,000 computed in accordance with FASB ASC Topic 718.

(4)

This amount includes Director Fees earned or paid in cash in the amount of $59,600$49,600 and dividends in the amount of $1,339.$1,521.

(5)

The Director Fees earned or paid in cash to Mr. Grayston during 20182019 and 20172018 represent remuneration for his service as a director of the Company and his service on certain committees of the Board.board of directors of the Company. Mr. Grayson does not receive compensation as our President.the President of the Company.

(6)

Represents the fair market value of phantom shares issued pursuant to Mr. Nieman’s Employment Agreement computedwhich is described in accordance with FASB ASC Topic 718.further detail in the section captioned “Executive Employment Agreements” below.

(7)

Represents the fair market value of option awards computed in accordance with FASB ASC Topic 718. The option award included 5,000 options granted to Mr. Nieman on January 1, 2018, which vest in five equal annual installments beginning on the first anniversary of the date of grant. The strike price for the options was based on net book value of our common stock as of December 31, 2017, which was $30.58.

 

11


OUTSTANDING EQUITY AWARDS AT FISCALYEAR-END

 

 Number of Shares
Underlying
Unexercised
Options
(Exercisable)
 Stock Option Plan
Awards: Number
of Shares
Underlying
Unexercised
Unearned Options
 Option
Exercise
Price
 Option
Expiration
Date
 Number of
Phantom
Shares That
Have Vested
 Fair Market
Value of
Phantom
Shares  That
Have
Vested(1)
 

Name

 (#) (#) ($) 

 

 (#) ($)  Number of Shares
Underlying
Unexercised
Options
(Exercisable)
 Stock Option Plan
Awards: Number
of Shares
Underlying
Unexercised
Unearned
Options
 Option
Exercise
Price
 Option
Expiration
Date
 Number of
Phantom
Shares
That Have
Vested
 Fair Market
Value of
Phantom
Shares That
Have
Vested(1)
 
Name (#) (#) ($) 

 

 (#) ($) 
            

2019 Phantom Share Award

  —     —     —     —     705   —   

2018 Option Award

  1,000   4,000  $30.58   1/1/2024         2,000   3,000  $30.58   1/1/2024   —    

2018 Phantom Share Award

              729      —     —     —     —     729   —   

2017 Phantom Share Award

              741      —     —     —     —     741   —   

2016 Phantom Share Award

              792      —     —     —     —     792   —   

2015 Phantom Share Award

              692      —     —     —     —     692   —   

2014 Phantom Share Award

              630      —     —     —     —     630   —   

2013 Phantom Share Award

              617      —     —     —     —     617   —   

2012 Phantom Share Award

              601      —     —     —     —     601   —   

2011 Phantom Share Award

              993      —     —     —     —     993   —   

2010 Phantom Share Award

              38,443      —     —     —     —     38,443   —   
 

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

 

Stuart Grayston

            

2017 Option Award

  2,000   3,000  $27.99   3/3/2023       3,000   2,000  $27.99   3/3/2023   —              
 

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

 

 

(1)

Determined by subtracting $1,500,000 from the product of (i) the number of phantom shares and (ii) the current fair market value of our Common Stock. Mr. Nieman’s phantom share account currently has no value based on the fair market value of our Common Stock.

Executive Employment Agreements

The following is a summary of the terms of the employment agreements or arrangements between us and our named executive officers.

Stuart H. Grayston

Mr. Grayston serves as our President but is not compensated for his services in such capacity. Mr. Grayston does receive compensation from us for service on the Board as one of our directors in the manner described above under the section captioned “Item 1—Election of Directors—Director Compensation”.

F. Kyle Nieman III

On November 24, 2009,May 20, 2019, Protexure entered into an employment agreement (the “Employment Agreement”) withand F. Kyle Nieman III with an initial term ending December 31, 2012 (with automaticone-year renewals thereafter)entered into a new employment agreement (the “2019 Employment Agreement”), pursuant to which, Mr. Nieman serves as President and Chief Executive Officer of Protexure. Mr. Nieman and Protexure agreed to amend theThe 2019 Employment Agreement provided for an initial term that ended on March 1, 2013 and December 31, 2014. We do not believe that either amendment to the Employment Agreement was material.2019, but established automaticone-year renewals thereafter. The material terms of the 2019 Employment Agreement, as amended, include the following:

 

The Board will determine, on an annual basis prior to October 15th of each year, Mr. Nieman’s annual salary for the following year. For the 2019 fiscal year, Mr. Nieman will be entitled to a base salary of $347,500. He will be eligible to receive annual bonuses based on meeting or exceeding certain revenue and operating income targets for Protexure.

The Board will determine, on an annual basis prior to October 15th of each year, Mr. Nieman’s annual salary for the following year. For the 2019 fiscal year, Mr. Nieman received a base salary of $347,500. For the 2020 fiscal year, Mr. Nieman will be entitled to a base salary of $347,500. He will be eligible to receive annual bonuses based on Protexure meeting or exceeding certain revenue and operating income targets.

 

Mr. Nieman will be entitled to full participation in all benefits plans and programs for which Protexure’s senior officers are or shall become eligible.

 

12


Contingent upon Mr. Nieman qualifying for a bonus, Mr. Nieman will be eligible to receive options to purchase shares of Common Stock over a five-year period at a price equal to the fair market value of the Common Stock as of the date each option is granted.

On January 1, 2010, Protexure created an account on behalf of Mr. Nieman comprised of approximately 37,509 phantom shares of Common Stock (calculated as $1,500,000 divided by $39.99, the then-current value of a share of Common Stock at December 31, 2009). The phantom shares are eligible for phantom dividends at the same rate paid on regular shares of Common Stock. The phantom dividends may be used only to purchase additional phantom shares. The purchase price of the phantom shares will be the then-current value of the Common Stock. As of December 31, 2018,2019, Mr. Nieman’s account consisted of 44,23844,943 phantom shares. Mr. Nieman’s interest in the phantom shares is fully vested. On June 6, 2019, the Company adopted the 2019 Phantom Share Plan (the “2019 Plan”). The phantom shares awarded to Mr. Nieman prior to the date of the 2019 Plan shall constitute one Incentive Share under the 2019 Plan, shall be subject to all of the terms and conditions of the 2019 Plan, and shall be vested in full. The proceeds of the phantom shares, less the initial value of $1,500,000, are to be paid in cash to Mr. Nieman at or after age 65 if retired, or within 6030 days in the event of his death or permanent disability. If Mr. Nieman is terminated other than for“for cause, the value of the phantom shares, less the initial value of $1,500,000, is to be paid in cash within 30 days following such termination. If Mr. Nieman resigns or is terminated for“for cause, the value of the phantom shares, less the initial value of $1,500,000, is to be paid in cash in five equal annual installments the first of which would be paid 30 days after the effective date of the termination or resignation.resignation; provided, however, that, in the event of Mr. Nieman’s resignation, the payment otherwise payable to him shall be reduced by 10%, and in the event of termination “for cause,” the payment otherwise payable to him shall be reduced by 20%. If there is a change in control or a sale or merger of Protexure, other than a transaction between us and any of our affiliates or subsidiaries, Mr. Nieman will have the right to receive the proceeds immediately. In the event of a sale or merger of us, for each share of phantom stock held, Mr. Nieman will be paid the aggregate value of the phantom shares based on the per share value used in the change in control, sale or the merger, less the initial account value of $1,500,000.$1,500,000 within 180 days after the consummation of such transaction.

 

IfIn the event Protexure terminates Mr. Nieman other than for “cause,Nieman’s employment “for cause,heMr. Nieman’s employment is entitled to receive 12 monthsterminated by reason of compensation, less all applicable and usual deductions.

Ifhis death or disability, or Mr. Nieman terminates his employment with Protexure, Protexure will have no further obligations to Mr. Nieman including, the payment of annual compensation, benefits orfor any other sumsreason other than as described in the paragraph above. However,for “good reason,” Mr. Nieman shall be entitled to sums pursuant to the terms ofno further compensation or benefits from Protexure other than (A) any plans under which he was receiving any benefits, or as otherwise provided by law, and the valueportion of his phantom shares (less the initial account value of $1,500,000). The proceeds ofannual base salary that had accrued but had not yet been paid (including any phantom shares willamount for accrued and unused vacation payable in accordance with Protexure’s vacation policy), (B) any bonus earned on apro-rata basis except if his termination is “for cause” then no bonus shall be paid, (C) any reimbursement due under Protexure’s standard business expense reimbursement policies, and (D) any amounts payable to him in five equal annual installments,under the first2019 Plan or any other incentive or deferred compensation plan as may exist at the time of which would be paid 30 days after the effective date of the termination.

 

If Protexure terminates Mr. Nieman’s employment for any reason (includingnon-renewal of the 2019 Employment Agreement) other than “for cause” or disability, or if Mr. Nieman terminates his employment because Protexure materially diminishes his duties as President and Chief Executive Officer of Protexure or significantly reduces his annual compensation or benefits,for “good reason,” Mr. Nieman wouldshall be entitled to all rightsreceive an amount equal to 100% of the his annual base salary, in addition to (A) any bonus earned on apro-rata basis, (B) any reimbursement due under Protexure’s standard business expense reimbursement policies, and benefits(C) any amounts payable to him under the terms2019 Plan or any other incentive or deferred compensation plan as may exist at the time of this Employment Agreement as if he were terminatedtermination.

During the employment period and for 12 months thereafter, Mr. Nieman shall not, directly or indirectly, anywhere in the United States, either for himself or through any other thanperson, have an ownership interest in, manage, participate, operate, control, permit Mr. Nieman’s name to be used by, perform services for “cause.”or otherwise become involved in, in a competing business.

 

If Mr. Nieman terminates his employment with Protexure under circumstances other than those where Protexure has materially diminished his duties, duringDuring the24-monthnon-compete time period immediately following such termination, Mr. Nieman may not work in the State of Illinois in a managerial or executive capacity for any insurance business that is or could be a competitor of Protexure. In addition, during that same24-month time period, Mr. Nieman mayshall not solicit any then-current employeesanywhere in the United States attempt to induce to leave the employ of Protexure to work foror hire any insurance business by which he is then employedcurrent employee or former employee within the last year, or in which he otherwise holds an ownership interest.any way interfere with the relationship between such employee and Protexure. Mr. Nieman is also restricted from soliciting or servicing any of Protexure’s current customers, former customers within the last year or prospective customers for the sale of goods or services competitive with those offered by Protexure.

 

13


Nonbinding Advisory Vote on Executive Compensation

At the 2016 Annual General Meeting, approximately 94% of our shareholders, represented in person or by proxy, voted in favor of the resolution to approve our executive compensation, on an advisory basis, and recommended that we hold our nonbinding advisory vote on executive compensation on a triennial basis. In accordance with the recommendations of our shareholders at the 2016 Annual General Meeting, we will hold a nonbinding advisory vote on executive compensation every three years. The next nonbinding advisory vote on executive compensation, after the vote being held at the 2019 Annual General Meeting, will be held at the 2022 Annual General Meeting. We will also hold a nonbinding advisory vote on the frequency of the advisory vote on executive compensation every six years as required under Regulation 14A of the Exchange Act. We are holding a vote on the frequency of the advisory vote on executive compensation at the 2019 Annual General Meeting and the next vote on frequency will be held at the 2025 Annual General Meeting.

14


ITEM 2—NONBINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION

Executive Compensation

We believe that our executive compensation program is designed to retain and motivate high-quality executive leadership with the talent to support the creation of long-term shareholder value. We have structured the compensation plan for our sole executive officer, F. Kyle Nieman III, the President and Chief Executive Officer of Protexure, such that significant elements of his total executive compensation package (cash and phantom stock incentives) are “at risk” elements that provide both upside potential and downside risk, ensuring that Mr. Nieman’s interests are aligned with those of shareholders. Mr. Grayston is included as a named executive officer solely due to his position as our principal executive officer despite the fact that he does not receive compensation directly for this role. As disclosed above, Mr. Grayston only receives compensation for his services as a member of our Board of Directors.

Shareholders are encouraged to carefully review the section of this Proxy Statement captioned “Executive Officers” above for a more detailed discussion of our executive compensation program.

In accordance with recently adopted Section 14A of the Exchange Act, and as a matter of good corporate governance, we are asking for shareholders to approve the following resolution:

“RESOLVED, that the compensation paid to the Company’s named executive officers, as disclosed pursuant to Item 402 of RegulationS-K, including compensation tables and narrative discussion is hereby APPROVED.”

Your vote is advisory and will not be binding upon our Board of Directors. However, the Board of Directors will take into account the outcome of the vote when considering future executive compensation arrangements.

The Board of Directors unanimously recommends that the shareholders vote “FOR” the approval of the compensation of the named executive officers as disclosed pursuant to Item 402 of RegulationS-K, including the compensation tables and narrative discussion.

15


ITEM 3—NONBINDING ADVISORY VOTE ON THE FREQUENCY OF A SHAREHOLDER

VOTE ON THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS

This proposal gives the Company’s shareholders the opportunity to vote, on an advisory basis, whether the frequency of a shareholder vote on the compensation of the named executive officers will be every one, two or three years. Shareholders may also abstain from voting on the frequency of a shareholder vote on executive compensation. Because the vote is advisory, it will not be binding upon the Company or its Board of Directors. However, the Board of Directors will take into account the outcome of the vote when considering the frequency of a shareholder vote on executive compensation.

After careful consideration, the Board of Directors has determined that having an advisory vote on the compensation of the named executive officers every three years is the best approach because only one of our named executive officers receives compensation for hisnon-director duties and an advisory vote occurring every three years will permit our shareholders to fully observe and evaluate the impact of any changes to our executive compensation philosophy and objectives which have occurred since the last advisory vote on executive compensation, including any changes in response to the outcome of a prior advisory vote on executive compensation. The Board of Directors unanimously recommends conducting a vote to approve the compensation of the named executive officers every 3 years.

Note: Shareholders are not voting to approve or disapprove this recommendation. Shareholders are voting on setting the frequency of the shareholder advisory vote on executive compensation at every “3 YEARS,” as recommended by the Board of Directors, “2 YEARS,” “1 YEAR,” or you may “ABSTAIN.”

The Board of Directors unanimously recommends that the shareholders vote for a frequency of every
“3 YEARS.”

16


ITEM 4—APPOINTMENT OF AUDITOR

Subject to your ratification, the Audit Committee of our Board of Directors has selected the accounting firm of Deloitte Ltd. to serve as our independent auditor for 2019.2020. Deloitte Ltd. has been our independent auditor since 1998.

Audit Fees andNon-Audit Fees

The following table summarizes the fees billed to us by Deloitte Ltd. for audit and other services for the periods indicated.

 

  2018   2017   2019   2018 

Audit Fees(1)

  $200,000   $185,000   $195,000   $203,000 

Audit-Related Fees

   —      —      —      —   

Tax Fees

   —      —      —      —   

All Other Fees

   —      —      —      —   
  

 

   

 

   

 

   

 

 

Total

  $200,000   $185,000   $195,000   $203,000 

 

(1)

Audit fees for 20182019 and 20172018 consist of professional services rendered for the annual audit and review of financial statements and the review of financial statements included in our quarterly reports.

Policy on Audit CommitteePre-Approval of Audit andNon-Audit Services

The Audit Committee’s policy is topre-approve all audit andnon-audit services provided by our independent auditor on acase-by-case basis. In making such determinations, the Audit Committee considers whether the provision ofnon-audit services is compatible with maintaining the auditor’s independence.

Representatives of Deloitte Ltd. are not expected to attend the Annual General Meeting. However, they will be available telephonically to respond to appropriate questions.

 

The Board recommends that you vote “FOR” ratification of the appointment of

Deloitte Ltd. as our independent auditor for the current fiscal year.

 

1714


OTHER MATTERS

Annual Report to Shareholders

We have mailed this proxy statement to each shareholder entitled to vote at the Annual General Meeting. A copy of our 20182019 annual report accompanies this proxy statement. Included in the 20182019 annual report are our consolidated financial statements for the fiscal year ended December 31, 2018.2019. You may obtain, at no charge, a copy of our Annual Report onForm10-K for the year ended December 31, 2018,2019, by contacting the Shareholder Services Division in writing at c/o Citadel Management Bermuda Limited, Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda; by phone at (441)295-6015; or via the Internet atwww.amerinst.bm/proxyStatements.html. As required by Section 84 of the Bermuda Companies Act, our consolidated financial statements, including the auditor’s report, will be presented at the Annual General Meeting, but no shareholder action will be required concerning those financial statements.

Solicitation of Proxies

We will pay the expenses of the preparation of the proxy materials and the solicitation by the Board of your proxy. We have engaged Broadridge Financial Solutions, Inc. to assist us in the tabulation of proxies, for which we will pay a fee of approximately $2,000. Our directors, officers and employees and Citadel Management Bermuda Limited, our management company, none of whom will receive any additional compensation for soliciting, may solicit your proxy by telephone or other means of communication. We will reimburse brokers and other nominees for costs they incur mailing proxy materials.

Shareholder Proposals for the 2020 Annual General Meeting

Shareholder proposals that are to be included in the Proxy Statement for the 20202021 Annual General Meeting must be received by December 28, 2019.20, 2020. Shareholder proposals for the 20202021 Annual General Meeting that are not intended to be included in the Proxy Statement for that meeting must be received by March 12, 2020,2021, or the Board of Directors can vote the proxies in its discretion on the proposal. Proposals must comply with the proxy rules and be submitted in writing to AmerInst Insurance Group, Ltd., c/o Citadel Management Bermuda Limited, Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda, attention: Corporate Secretary.

Director Nominations

Shareholders entitled to vote generally in the election of directors may recommend a candidate for nomination as a director. A shareholder may recommend a director nominee for election at the 20202021 Annual General Meeting by timely submitting the name and qualifications of the candidate to our Governance and Nominating Committee. To be considered timely, recommendations must be received no earlier than 180 days and no later than 120 days prior to April 26, 2020,27, 2021, the first anniversary of this year’s Notice of Annual General Meeting date. In other words, recommendations must be received no earlier than October 29, 2019,2020, and no later than December 28, 2019.2020. Recommendations must be submitted in writing to AmerInst Insurance Group, Ltd., c/o Citadel Management Bermuda Limited, Continental Building, 25 Church Street, Continental Building, P.O. Box HM 1601, Hamilton, HM GX, Bermuda, attention: Corporate Secretary. Recommendations meeting these requirements will be brought to the attention of our Governance and Nominating Committee. Candidates recommended by shareholders are afforded the same consideration as candidates identified by our directors, executive officers, or search firms, if any, employed by us.

By order of the Board of Directors

 

LOGO

IRVIN F. DIAMOND

Chairman of the Board

AmerInst Insurance Group, Ltd.

 

1815


            AMERINST INSURANCE GROUP, LTD.LOGO

            PO BOX HM 1601

            HAMILTON, HM GX, BERMUDA

co VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

NY11717. AlfERINST INSURANCE GROUP, LTD. PO BOX HH 1601 HAifiLTON, HH GX, BERHUDA TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:

KEEP THIS PORTION FOR YOUR RECORDS
— — — — — — — — — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — 
DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. For Withhold For All To withhold authority to vote for All All Except individual nominee(s), mark “For The Board of Directors recommends you vote FOR the following director nominee(&): 1. Election of Director(s) Nominees 0 0 0 Except” and write nominee(s) on the 01 Irvin F. Diamond 02 Jeffry I. Gill man 03 David R. Klunk The Board of Directors recommends you vote FOR the following proposal: 2. To ratify the appointment of Deloitte Ltd. as our independent auditor for fiscal year 2020. the number(s) line below. NOTE: This proxy will be voted as directed, but if no directions are given on the proxy the shares represented by the proxy will be voted “FOR” proposals 1 and 2 and as determined by the proxies on any matter which may properly be brought at the meeting. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Signature (Joint Owners) of KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY any All the For Against Abstain 0 0 0

For

Withhold 

For All    

To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.

AllAll Except    
The Board of Directors recommends you vote FOR the following director nominee(s):

1.Election of Director(s)
Nominees
01Stuart H. Grayston                     02     Jerome A. Harris                     03     David N. Thompson
The Board of Directors recommends you vote FOR the following proposal:ForAgainst Abstain    
2.To consider and approve a non-binding advisory proposal on executive compensation.

NOTE:This proxy will be voted as directed, but if no directions are given on the proxy the shares represented by the proxy will be voted “FOR” proposals 1, 2 and 4 and “3 years” for proposal 3 and as determined by the proxies on any matter which may properly be brought at the meeting.

The Board of Directors recommends you vote 3 YEARS on the following proposal:

1 year 2 years3 yearsAbstain    

3.

To recommend, by non-binding vote, the frequency of executive compensation votes.

The Board of Directors recommends you vote FOR the following proposal:ForAgainst Abstain    
4.To ratify the appointment of Deloitte Ltd. as our independent advisor for fiscal year 2019.

LOGO

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
Signature [PLEASE SIGN WITHIN BOX]        DateSignature (Joint Owners)Date      


LOGO

co I N Ln g 0 0 0 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice & Proxy Statement, Annual Report is/ are available at www.proxwote.com REVOCABLE PROXY AMERINST INSURANCE GROUP, LTD. This proxy is solicited on behalf of the Board of Directors for the Annual General Meeting to be held on June 3, 2020. Thomas R. McMahon and Christopher F. Russin, or either of them, are designated as proxies, with full power of substitution, to vote all the Common Shares of Amerlnst Insurance Group, Ltd. (the “Company”) which the undersigned may be entitled to vote at the Annual General Meeting to be held on June 3, 2020, or at any adjournment thereof, as specified on the reverse side of this card. The Company’s directors recommend a vote FOR the election of the director nominee(s) listed and a vote FOR the appointment of Deloitte Ltd. as the Company’s independent auditors. The proxies shall vote as specified, but if no choice is specified the proxies shall vote in accordance with the recommendations of the Company’s directors. If other business is presented at the Annual General Meeting, this proxy shall be voted in accordance with the judgment of the proxies on those matters. YOUR VOTE IS IMPORTANT! PLEASE SIGN AND DATE BELOW AND RETURN PROMPTLY IN THE POSTAGE-PAID ENVELOPE Continued and to be signed on reverse side

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice & Proxy Statement, Annual Report, Supplement is/are available atwww.proxyvote.com

— — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — — — — — — — — — — — — — — — — — —  — — — — — — — — — 

LOGO

REVOCABLE PROXY

AMERINST INSURANCE GROUP, LTD.

This proxy is solicited on behalf of the Board of Directors

for the Annual General Meeting to be held on June 6, 2019.

Irvin F. Diamond and Jerome A. Harris, or either of them, are designated as proxies, with full power of substitution, to vote all the Common Shares of AmerInst Insurance Group, Ltd. (the “Company”) which the undersigned may be entitled to vote at the Annual General Meeting to be held on June 6, 2019, or at any adjournment thereof, as specified on the reverse side of this card.

The Company’s directors recommend a vote FOR the election of the director nominee(s) listed, a vote FOR approval of the advisory vote on executive compensation, 3 YEARS for the frequency of the advisory vote on executive compensation and a vote FOR the appointment of Deloitte Ltd. as the Company’s independent auditors. The proxies shall vote as specified, but if no choice is specified the proxies shall vote in accordance with the recommendations of the Company’s directors. If other business is presented at the Annual General Meeting, this proxy shall be voted in accordance with the judgment of the proxies on those matters.

YOUR VOTE IS IMPORTANT! PLEASE SIGN AND DATE BELOW AND RETURN PROMPTLY IN THE POSTAGE-PAID ENVELOPE

Continued and to be signed on reverse side